MapLight Therapeutics, Inc. Common Stock (MPLT) — Financial Flexibility Index
MapLight Therapeutics, Inc. Common Stock (MPLT) has a Financial Flexibility Index of -2.24x as of June 2026. Free cash flow of $-44.85 Million (operating CF $-44.87 Million minus capex $22.00K) represents -2% of total liabilities ($20.05 Million). Check how tangible is MapLight Therapeutics, Inc. Common Stock's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MapLight Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for MapLight Therapeutics, Inc. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of MapLight Therapeutics, Inc. Common Stock.
Annual Financial Flexibility Index for MapLight Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for MapLight Therapeutics, Inc. Common Stock. Explore how well can MapLight Therapeutics, Inc. Common Stock service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.51x | $-137.66 Million | $-138.14 Million | $21.14 Million | ▼ -81.2% |
| 2024 | -3.59x | $-78.05 Million | $-78.81 Million | $21.72 Million | ▼ -40.3% |
| 2023 | -2.56x | $-51.54 Million | $-52.01 Million | $20.13 Million | ▼ -83.6% |
| 2022 | -1.39x | $-25.83 Million | $-26.58 Million | $18.52 Million | — |